Salud financiera de hoja de balance de Alphamab Oncology
Salud financiera controles de criterios 5/6
Alphamab Oncology has a total shareholder equity of CN¥1.6B and total debt of CN¥320.0M, which brings its debt-to-equity ratio to 19.6%. Its total assets and total liabilities are CN¥2.1B and CN¥513.3M respectively.
Información clave
19.6%
Ratio deuda-patrimonio
CN¥320.00m
Deuda
Ratio de cobertura de intereses | n/a |
Efectivo | CN¥1.46b |
Patrimonio | CN¥1.63b |
Total pasivo | CN¥513.25m |
Activos totales | CN¥2.14b |
Actualizaciones recientes sobre salud financiera
Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05Recent updates
Alphamab Oncology (HKG:9966) Stocks Shoot Up 91% But Its P/S Still Looks Reasonable
Sep 30Some Alphamab Oncology (HKG:9966) Shareholders Look For Exit As Shares Take 48% Pounding
Jun 20Alphamab Oncology's (HKG:9966) Shares Climb 27% But Its Business Is Yet to Catch Up
May 06Optimistic Investors Push Alphamab Oncology (HKG:9966) Shares Up 27% But Growth Is Lacking
Mar 13Subdued Growth No Barrier To Alphamab Oncology's (HKG:9966) Price
Jan 17Slammed 40% Alphamab Oncology (HKG:9966) Screens Well Here But There Might Be A Catch
May 21Newsflash: Alphamab Oncology (HKG:9966) Analysts Have Been Trimming Their Revenue Forecasts
Mar 01Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05Análisis de la situación financiera
Pasivos a corto plazo: 9966's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥345.4M).
Pasivo a largo plazo: 9966's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥167.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 9966 has more cash than its total debt.
Reducción de la deuda: 9966 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 9966 has sufficient cash runway for more than 3 years based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if 9966 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.